$ENTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENANTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ENANTA PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | Peterson Kristine | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 4,872 | 57,343 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 3,672 | 43,219 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.18 | 5,149 | 73,013 | 0 | |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 4,872 | 57,343 | 330,918 | 326 K to 330.9 K (+1.49 %) |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 3,672 | 43,219 | 326,046 | 322.4 K to 326 K (+1.14 %) |
| Jan 28 2021 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.18 | 5,149 | 73,013 | 322,374 | 317.2 K to 322.4 K (+1.62 %) |
| Jan 27 2021 | ENTA | ENANTA PHARMACEUTI ... | Luu Brendan | Sr. VP, Business De ... | Option Exercise | A | 48.03 | 75,000 | 3,602,250 | 75,000 | |
| Jan 08 2021 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.58 | 6,000 | 273,463 | 61,759 | 67.8 K to 61.8 K (-8.85 %) |
| Jan 08 2021 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 45.58 | 6,000 | 273,463 | 61,759 | 67.8 K to 61.8 K (-8.85 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 0.00 | 5,250 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 42.52 | 1,540 | 65,481 | 42,248 | 43.8 K to 42.2 K (-3.52 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 0.00 | 5,250 | 0 | 43,788 | 38.5 K to 43.8 K (+13.62 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.00 | 2,625 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 42.52 | 770 | 32,740 | 55,759 | 56.5 K to 55.8 K (-1.36 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.00 | 2,625 | 0 | 56,529 | 53.9 K to 56.5 K (+4.87 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 5,250 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 42.52 | 1,540 | 65,481 | 26,944 | 28.5 K to 26.9 K (-5.41 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 5,250 | 0 | 28,484 | 23.2 K to 28.5 K (+22.60 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 0.00 | 5,250 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 42.52 | 1,540 | 65,481 | 317,225 | 318.8 K to 317.2 K (-0.48 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 0.00 | 5,250 | 0 | 318,765 | 313.5 K to 318.8 K (+1.67 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.00 | 7,500 | 0 | 0 | |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 42.52 | 2,201 | 93,587 | 681,488 | 683.7 K to 681.5 K (-0.32 %) |
| Dec 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.00 | 7,500 | 0 | 683,689 | 676.2 K to 683.7 K (+1.11 %) |
| Dec 08 2020 | ENTA | ENANTA PHARMACEUTI ... | Kieffer Tara Lynn | Sr. VP, New Product ... | Option Exercise | A | 42.62 | 65,000 | 2,770,300 | 65,000 | |
| Dec 07 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 1,667 | 50,010 | 13,667 | |
| Dec 07 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 1,667 | 50,010 | 38,538 | 36.9 K to 38.5 K (+4.52 %) |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 43.57 | 30,800 | 1,341,956 | 30,800 | |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 7,600 | 0 | 36,871 | 29.3 K to 36.9 K (+25.96 %) |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 43.57 | 30,800 | 1,341,956 | 30,800 | |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 7,600 | 0 | 23,234 | 15.6 K to 23.2 K (+48.61 %) |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | A | 43.57 | 30,800 | 1,341,956 | 30,800 | |
| Nov 20 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 7,600 | 0 | 313,515 | 305.9 K to 313.5 K (+2.48 %) |
| Nov 12 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 2.54 | 3,480 | 8,849 | 0 | |
| Nov 12 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 2.54 | 3,480 | 8,849 | 46,304 | 42.8 K to 46.3 K (+8.13 %) |
| Aug 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 1,666 | 49,980 | 15,334 | |
| Aug 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 1,666 | 49,980 | 29,271 | 27.6 K to 29.3 K (+6.04 %) |
| Jul 01 2020 | ENTA | ENANTA PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 49.04 | 17,000 | 833,680 | 17,000 | |
| May 07 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 1.21 | 1,740 | 2,100 | 0 | |
| May 07 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 1.21 | 1,740 | 2,100 | 42,824 | 41.1 K to 42.8 K (+4.24 %) |
| Mar 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 3,000 | 90,000 | 17,000 | |
| Mar 16 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 3,000 | 90,000 | 27,605 | 24.6 K to 27.6 K (+12.19 %) |
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Peterson Kristine | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 52.76 | 3,122 | 164,717 | 649,689 | 652.8 K to 649.7 K (-0.48 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,910 | 0 | 652,811 | 643.9 K to 652.8 K (+1.38 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 1,485 | 0 | 643,901 | 642.4 K to 643.9 K (+0.23 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 52.76 | 940 | 49,594 | 24,605 | 25.5 K to 24.6 K (-3.68 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,475 | 0 | 25,545 | 23.1 K to 25.5 K (+10.73 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 412 | 0 | 23,070 | 22.7 K to 23.1 K (+1.82 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 52.76 | 1,091 | 57,561 | 15,634 | 16.7 K to 15.6 K (-6.52 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,925 | 0 | 16,725 | 13.8 K to 16.7 K (+21.20 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 487 | 0 | 13,800 | 13.3 K to 13.8 K (+3.66 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 52.76 | 1,089 | 57,456 | 305,915 | 307 K to 305.9 K (-0.35 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 2,925 | 0 | 307,004 | 304.1 K to 307 K (+0.96 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 487 | 0 | 304,079 | 303.6 K to 304.1 K (+0.16 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 52.76 | 545 | 28,754 | 41,084 | 41.6 K to 41.1 K (-1.31 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 1,350 | 0 | 41,629 | 40.3 K to 41.6 K (+3.35 %) |
| Feb 18 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 225 | 0 | 40,279 | 40.1 K to 40.3 K (+0.56 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 63.88 | 2,331 | 148,904 | 22,658 | 25 K to 22.7 K (-9.33 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 0.00 | 5,250 | 0 | 24,989 | 19.7 K to 25 K (+26.60 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 63.88 | 2,331 | 148,904 | 13,313 | 15.6 K to 13.3 K (-14.90 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 5,250 | 0 | 15,644 | 10.4 K to 15.6 K (+50.51 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 0.00 | 5,250 | 0 | 5,250 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 63.88 | 2,331 | 148,904 | 303,592 | 305.9 K to 303.6 K (-0.76 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 0.00 | 5,250 | 0 | 305,923 | 300.7 K to 305.9 K (+1.75 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 63.88 | 3,330 | 212,720 | 642,416 | 645.7 K to 642.4 K (-0.52 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.00 | 7,500 | 0 | 645,746 | 638.2 K to 645.7 K (+1.18 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.00 | 2,625 | 0 | 2,625 | |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 61.66 | 721 | 44,458 | 40,054 | 40.8 K to 40.1 K (-1.77 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Sell | S | 60.82 | 9,279 | 564,341 | 40,775 | 50.1 K to 40.8 K (-18.54 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 63.88 | 1,165 | 74,420 | 50,054 | 51.2 K to 50.1 K (-2.27 %) |
| Jan 06 2020 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.00 | 2,625 | 0 | 51,219 | 48.6 K to 51.2 K (+5.40 %) |
| Nov 25 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 1,592 | 50,021 | 19,818 | |
| Nov 25 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 1,592 | 50,021 | 19,739 | 18.1 K to 19.7 K (+8.77 %) |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 63.35 | 110,000 | 6,968,500 | 110,000 | |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
| Nov 18 2019 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Option Exercise | A | 63.35 | 30,000 | 1,900,500 | 30,000 | |
| Oct 09 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 14.18 | 7,052 | 99,997 | 16,149 | |
| Oct 09 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 14.18 | 7,052 | 99,997 | 638,246 | 631.2 K to 638.2 K (+1.12 %) |
| Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 5,000 | 150,000 | 20,000 | |
| Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 5,000 | 150,000 | 19,871 | 14.9 K to 19.9 K (+33.62 %) |
| Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 30.00 | 5,000 | 150,000 | 20,000 | |
| Sep 30 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 30.00 | 5,000 | 150,000 | 19,871 | 14.9 K to 19.9 K (+33.62 %) |
| Jun 26 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 3,295 | 103,529 | 21,410 | |
| Jun 26 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 3,295 | 103,529 | 14,871 | 11.6 K to 14.9 K (+28.46 %) |
| Mar 12 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | M | 23.40 | 1,546 | 36,176 | 0 | |
| Mar 12 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Sell | S | 99.16 | 1,546 | 153,301 | 0 | 1.5 K to 0 (-100.00 %) |
| Mar 12 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Buy | M | 23.40 | 1,546 | 36,176 | 1,546 | 0 to 1.5 K |
| Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 31.42 | 795 | 24,979 | 24,705 | |
| Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 1,724 | 59,823 | 70,976 | |
| Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 31.42 | 795 | 24,979 | 26,497 | 25.7 K to 26.5 K (+3.09 %) |
| Mar 07 2019 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 1,724 | 59,823 | 25,702 | 24 K to 25.7 K (+7.19 %) |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 36.61 | 9,280 | 339,741 | 0 | |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 103.65 | 9,280 | 961,897 | 0 | 9.3 K to 0 (-100.00 %) |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 36.61 | 9,280 | 339,741 | 9,280 | 0 to 9.3 K |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 36.61 | 9,280 | 339,741 | 0 | |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 103.65 | 9,280 | 961,897 | 0 | 9.3 K to 0 (-100.00 %) |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 36.61 | 9,280 | 339,741 | 9,280 | 0 to 9.3 K |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Russell Lesley | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Peterson Kristine | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 88.88 | 20,730 | 1,842,482 | 631,194 | 651.9 K to 631.2 K (-3.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 651,924 | 615.9 K to 651.9 K (+5.84 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 14,400 | 0 | 615,924 | 601.5 K to 615.9 K (+2.39 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.18 | 8,772 | 124,387 | 5,149 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 14.00 | 6,956 | 97,384 | 13,926 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Option Exercise | M | 11.77 | 10,249 | 120,631 | 3,672 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 88.88 | 6,993 | 621,538 | 310,673 | 317.7 K to 310.7 K (-2.20 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 11,250 | 0 | 317,666 | 306.4 K to 317.7 K (+3.67 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 4,500 | 0 | 306,416 | 301.9 K to 306.4 K (+1.49 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 90.07 | 6,297 | 567,173 | 301,916 | 308.2 K to 301.9 K (-2.04 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 91.24 | 171 | 15,602 | 308,213 | 308.4 K to 308.2 K (-0.06 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 90.11 | 2,707 | 243,936 | 308,384 | 311.1 K to 308.4 K (-0.87 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 89.50 | 18,971 | 1,697,878 | 311,091 | 330.1 K to 311.1 K (-5.75 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Sell | S | 88.66 | 5,835 | 517,321 | 330,062 | 335.9 K to 330.1 K (-1.74 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.18 | 8,772 | 124,387 | 335,897 | 327.1 K to 335.9 K (+2.68 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 14.00 | 6,956 | 97,384 | 327,125 | 320.2 K to 327.1 K (+2.17 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Buy | M | 11.77 | 10,249 | 120,631 | 320,169 | 309.9 K to 320.2 K (+3.31 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 29.02 | 7,500 | 217,650 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 3,728 | 95,362 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 2,272 | 58,118 | 3,728 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.07 | 11,228 | 1,011,301 | 0 | 11.2 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 29.02 | 7,500 | 217,650 | 11,228 | 3.7 K to 11.2 K (+201.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 3,728 | 95,362 | 3,728 | 0 to 3.7 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.03 | 2,272 | 204,552 | 0 | 2.3 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 2,272 | 58,118 | 2,272 | 0 to 2.3 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | M | 23.40 | 5,000 | 117,000 | 1,546 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | M | 23.40 | 2,734 | 63,976 | 6,546 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Sell | S | 90.00 | 5,000 | 450,000 | 0 | 5 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Buy | M | 23.40 | 5,000 | 117,000 | 5,000 | 0 to 5 K |